Evidence map›Paper›PMID 32938360›Full record

ArticleBMC bioinformatics2020

A preliminary PET radiomics study of brain metastases using a fully automatic segmentation method.

Alessandro Stefano, Albert Comelli, Valentina Bravatà, Stefano Barone, Igor Daskalovski, Gaetano Savoca, Maria Gabriella Sabini, Massimo Ippolito, Giorgio Russo

Abstract read
In one paragraph

Article in BMC bioinformatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alessandro StefanoInstitute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Cefalù, Italy.
Albert ComelliInstitute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Cefalù, Italy.
Valentina BravatàInstitute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Cefalù, Italy. valentina.bravata@ibfm.cnr.it.ORCID http://orcid.org/0000-0001-9778-9252
Stefano BaroneUniversity of Palermo, Palermo, Italy.
Igor DaskalovskiDepartment of Physics and Astronomy, University of Catania, Catania, Italy.
Gaetano SavocaInstitute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Cefalù, Italy.
Maria Gabriella SabiniMedical Physics Unit, Cannizzaro Hospital, Catania, Italy.
Massimo IppolitoNuclear Medicine Department, Cannizzaro Hospital, Catania, Italy.
Giorgio RussoInstitute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Cefalù, Italy.

Funding

Italian Ministry of Economic Development Grant No. F/090012/01-02/X36
6 · The paper itself

Abstract

backgroundPositron Emission Tomography (PET) is increasingly utilized in radiomics studies for treatment evaluation purposes. Nevertheless, lesion volume identification in PET images is a critical and still challenging step in the process of radiomics, due to the low spatial resolution and high noise level of PET images. Currently, the biological target volume (BTV) is manually contoured by nuclear physicians, with a time expensive and operator-dependent procedure. This study aims to obtain BTVs from cerebral metastases in patients who underwent L-[

resultsFor predictive evaluation, 3 features (asphericity, low-intensity run emphasis, and complexity) were able to discriminate between responder and non-responder patients, after feature reduction and selection. Best performance in patient discrimination was obtained using the combination of the three selected features (sensitivity 81.23%, specificity 73.97%, and accuracy 78.27%) compared to the use of all features. Secondly, for follow-up evaluation, 8 features (SUV

conclusionsThe proposed system is able i) to extract 108 features for each automatically segmented lesion and ii) to select a sub-panel of 11C-MET PET features (3 and 8 in the case of predictive and follow-up evaluation), with valuable association with patient outcome. We believe that our model can be useful to improve treatment response and prognosis evaluation, potentially allowing the personalization of cancer treatment plans.

Indexed as

Brain NeoplasmsFemaleHumansMaleMiddle AgedNeoplasm MetastasisPositron-Emission TomographyPrognosisActive contourBiological target volumeCancerPositron emission tomographyRadiomics

Identifiers

PMID32938360
PMCPMC7493376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.